Gilon Co., Ltd. (CEO Kim Nam-seon) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
GilOn, established in 2019, is a digital healthcare solution company based on gait analysis. We have owned and commercialized smart insoles (I-SOL) as a gait measurement product, and have secured reliability through the development of algorithms for extracting various gait parameters for healthcare services, clinical trials and papers with hospitals, and comparative experiments with existing devices. Gilon’s explanation is that there is.
We have gait analysis equipment that can be used in hospitals and public health centers as well as personal products, and GDCA_MD (gait analysis and walking ability evaluation equipment) has been confirmed by the Health Insurance Review and Assessment Service as non-reimbursable for dynamic foot pressure testing (EZ-777). Currently, through collaboration with domestic hospitals and AI organizations, we are focusing on developing silver care solutions, including AI solutions for predicting various geriatric diseases that are expressed as gait abnormalities during daily life.
Gilon has developed four types of products based on gait analysis using smart insoles (I-SOL) with built-in pressure sensors and acceleration sensors and will introduce them at this exhibition.
Specifically, ▲I-SOL SMART is a B2C app that provides the right walking coaching solution by analyzing walking and activity data. A B2C app that adds the ‘gait evaluation’ function to I-SOL SMART ▲I-SOL CARE allows testing of walking ability, dynamic balance, and static balance. In addition, ▲I-SOL SDK is a development tool for developing various solutions based on I-SOL. I-SOL SDK enables the development of new and diverse app services. Lastly, ▲GDCA_MD is a specialized gait analysis equipment that can obtain raw data of I-SOL and various gait parameters. It can be used in a variety of ways, including gait analysis/evaluation and gait/physical ability evaluation by performing a professional gait analysis protocol.
Gilon officials said, “Gait is one of the important biomarkers that expresses the state of the body, and we aim to develop a product that can predict disease by constantly monitoring abnormalities in gait during daily life and enable early treatment through quick hospital visits. “We are doing it,” he said.
He continued, “GilOn’s products entered the market through LS Networks’ Prospecs brand. “We supplied smart insoles and solutions in 2018, and signed an additional smart insole supply contract in 2022,” he said, explaining the achievements so far. “We will not rest on our laurels, but will provide integrated dementia cognitive/exercise rehabilitation services, weight estimation AI services, and fall prediction. It is being developed to launch an AI service. “We are also developing a smart step box with a built-in wearable sensor, and plan to provide rehabilitation and fitness content services.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.